Although the 25-(OH) D levels and CD4+ T cell counts in the Low-25(OH)D group exhibited increasing trends during conventional anti-TB therapy, their levels remained significantly lower than in the Normal-25(OH)D group at all time points (all P < 0.05) (Fig. 2 A, B). The gene discussed is CD4; the disease is tuberculosis.